StockData
CEL SCI Corp logo

CEL SCI Corp (CVM) stock

CVMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$1.85+0.19 (+11.45%)

Close on Nov 17, 2026Market cap $32.54MP/E –Yield –

Cel Sci operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Cel Sci's operating income for the twelve months ending Jun 30, 2026 was -$22.29M. For fiscal 2025 it was -$24.81M. The highest annual figure on record is -$12.02M in fiscal 2009.

Annual operating income

PeriodPeriod endValueChange
FY2025Sep 30, 2025-$24.81M–
FY2024Sep 30, 2024-$26.35M–
FY2023Sep 30, 2023-$31.48M–
FY2022Sep 30, 2022-$36.06M–
FY2021Sep 30, 2021-$36.19M–
FY2020Sep 30, 2020-$28.99M–
FY2019Sep 30, 2019-$20.20M–
FY2018Sep 30, 2018-$16.77M–
FY2017Sep 30, 2017-$21.41M–
FY2016Sep 30, 2016-$23.65M–
FY2015Sep 30, 2015-$32.39M–
FY2014Sep 30, 2014-$25.67M–
FY2013Sep 30, 2013-$19.87M–
FY2012Sep 30, 2012-$17.24M–
FY2011Sep 30, 2011-$17.99M–
FY2010Sep 30, 2010-$18.56M–
FY2009Sep 30, 2009-$12.02M–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026-$5.56M–
Q2 FY2026CQ1 2026Mar 31, 2026-$5.33M–
Q1 FY2026CQ4 2025Dec 31, 2025-$5.37M–
Q4 FY2025CQ3 2025Sep 30, 2025-$6.03M–
Q3 FY2025CQ2 2025Jun 30, 2025-$5.49M–
Q2 FY2025CQ1 2025Mar 31, 2025-$6.39M–
Q1 FY2025CQ4 2024Dec 31, 2024-$6.89M–
Q4 FY2024CQ3 2024Sep 30, 2024-$6.12M–
Q3 FY2024CQ2 2024Jun 30, 2024-$6.67M–
Q2 FY2024CQ1 2024Mar 31, 2024-$7.08M–
Q1 FY2024CQ4 2023Dec 31, 2023-$6.49M–
Q4 FY2023CQ3 2023Sep 30, 2023-$7.47M–
Q3 FY2023CQ2 2023Jun 30, 2023-$8.18M–
Q2 FY2023CQ1 2023Mar 31, 2023-$8.18M–
Q1 FY2023CQ4 2022Dec 31, 2022-$7.65M–
Q4 FY2022CQ3 2022Sep 30, 2022-$8.95M–
Q3 FY2022CQ2 2022Jun 30, 2022-$8.72M–
Q2 FY2022CQ1 2022Mar 31, 2022-$9.55M–
Q1 FY2022CQ4 2021Dec 31, 2021-$8.84M–
Q4 FY2021CQ3 2021Sep 30, 2021-$8.47M–
Q3 FY2021CQ2 2021Jun 30, 2021-$10.46M–
Q2 FY2021CQ1 2021Mar 31, 2021-$8.53M–
Q1 FY2021CQ4 2020Dec 31, 2020-$8.73M–
Q4 FY2020CQ3 2020Sep 30, 2020-$8.44M–
Q3 FY2020CQ2 2020Jun 30, 2020-$6.97M–
Q2 FY2020CQ1 2020Mar 31, 2020-$6.72M–
Q1 FY2020CQ4 2019Dec 31, 2019-$6.86M–
Q4 FY2019CQ3 2019Sep 30, 2019-$5.64M–
Q3 FY2019CQ2 2019Jun 30, 2019-$5.21M–
Q2 FY2019CQ1 2019Mar 31, 2019-$4.31M–
Q1 FY2019CQ4 2018Dec 31, 2018-$5.03M–
Q4 FY2018CQ3 2018Sep 30, 2018-$3.53M–
Q3 FY2018CQ2 2018Jun 30, 2018-$4.09M–
Q2 FY2018CQ1 2018Mar 31, 2018-$4.22M–
Q1 FY2018CQ4 2017Dec 31, 2017-$4.93M–
Q4 FY2017CQ3 2017Sep 30, 2017-$3.80M–
Q3 FY2017CQ2 2017Jun 30, 2017-$4.76M–
Q2 FY2017CQ1 2017Mar 31, 2017-$7.91M–
Q1 FY2017CQ4 2016Dec 31, 2016-$4.94M–
Q4 FY2016CQ3 2016Sep 30, 2016-$6.64M–

More Cel Sci figures

See a number that looks wrong?